https://pelagepharma.com/press-releases/ 2026-08-14T15:37:33+00:00 https://pelagepharma.com/press-releases/pelage-presents-late-breaking-data-at-aad-2024-meeting-demonstrating-pp405-activates-human-hair-follicle-stem-cells-ex-vivo-and-in-phase-1-clinical-study/ 2026-07-25T02:49:03+00:00 https://pelagepharma.com/press-releases/pelage-pharmaceuticals-advances-clinical-program-with-first-patients-dosed-in-phase-2-study-for-hair-loss-and-gv-led-14m-series-a-1/ 2026-07-25T02:49:03+00:00 https://pelagepharma.com/press-releases/pelage-pharmaceuticals-announces-positive-phase-2a-clinical-trial-results-for-pp405-in-regenerative-hair-loss-therapy/ 2026-07-25T02:49:03+00:00 https://pelagepharma.com/press-releases/pelage-pp405-aad-2026/ 2026-07-25T02:49:03+00:00 https://pelagepharma.com/press-releases/pelage-pharmaceuticals-announces-120-million-series-b-financing-to-advance-regenerative-medicine-treatments-for-hair-loss/ 2026-07-25T02:49:03+00:00 https://pelagepharma.com/press-releases/pelage-pharmaceuticals-appoints-new-board-member-and-expands-executive-leadership-team/ 2026-07-25T02:49:03+00:00 https://pelagepharma.com/press-releases/pelage-pharmaceuticals-announces-16-75m-series-a-financing-led-by-gv-to-revolutionize-regenerative-medicine-for-hair-loss/ 2026-07-25T02:49:04+00:00